Insider Trading & Ownership - DENYES NANCY

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for DENYES NANCY
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-05-20
Sale
2020-05-28
8:26 pm
aTYR PHARMA INCLIFEDENYES NANCY
General Counsel
322$3.62$1,16632,735
(Direct)
View
2019-05-17
Sale
2019-05-20
4:38 pm
aTYR PHARMA INCLIFEKrueger Nancy
General Counsel
4,651$0.4501$2,09337,848
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-02-05
Exercise
2024-02-06
8:15 pm
N/A
N/A
aTYR PHARMA INCLIFEDENYES NANCY
General Counsel
2,688$020,141
(Direct)
View
2024-01-05
Option Award
2024-01-09
7:30 pm
N/A
2034-01-05
aTYR PHARMA INCLIFEDENYES NANCY
General Counsel
150,000$0162,079
(Direct)
View
2023-02-16
Option Award
2023-02-21
5:00 pm
N/A
2033-02-16
aTYR PHARMA INCLIFEDENYES NANCY
General Counsel
84,023$084,023
(Direct)
View
2023-02-03
Exercise
2023-02-06
7:03 pm
N/A
N/A
aTYR PHARMA INCLIFEDENYES NANCY
General Counsel
2,688$015,141
(Direct)
View
2022-05-24
Option Award
2022-05-26
4:34 pm
N/A
2032-05-24
aTYR PHARMA INCLIFEDENYES NANCY
General Counsel
88,097$091,544
(Direct)
View
2022-02-03
Option Award
2022-02-07
4:59 pm
N/A
2032-02-03
aTYR PHARMA INCLIFEDENYES NANCY
General Counsel
32,250$032,250
(Direct)
View
2021-05-21
Option Award
2021-05-25
9:06 pm
N/A
2025-05-21
aTYR PHARMA INCLIFEDENYES NANCY
General Counsel
59,000$062,091
(Direct)
View
2021-02-04
Option Award
2021-02-08
8:13 pm
N/A
2031-02-04
aTYR PHARMA INCLIFEDENYES NANCY
General Counsel
45,000$045,000
(Direct)
View
2020-05-26
Option Award
2020-05-28
8:26 pm
N/A
2030-05-26
aTYR PHARMA INCLIFEDENYES NANCY
General Counsel
30,000$032,735
(Direct)
View
2020-05-16
Exercise
2020-05-28
8:26 pm
N/A
N/A
aTYR PHARMA INCLIFEDENYES NANCY
General Counsel
892$032,735
(Direct)
View
2020-02-05
Option Award
2020-02-07
7:34 pm
N/A
2030-02-05
aTYR PHARMA INCLIFEDENYES NANCY
General Counsel
13,778$013,778
(Direct)
View
2019-05-16
Exercise
2019-05-20
4:38 pm
N/A
N/A
aTYR PHARMA INCLIFEKrueger Nancy
General Counsel
12,500$037,848
(Direct)
View